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Poly(L-lactic acid), a synthetic biodegradable polyester, is widely
accepted for many tissue engineering applications. Hyaluronic acid
(HA), as a polysaccharide of the extra cellular matrix (ECM),
besides exhibiting an excellent biocompatibility, inﬂuences cell
signaling, growth and differentiation. A combination between
these materials might be interesting for tissue engineering studies.
However, HA must be chemically modiﬁed for this use because
of its easy dissolution in water and quick degradation in biological
environments. Glutaraldehyde, GA, has been proposed as cross-
linking agent to produce HA hydrogels. However, accordingly to
the literature, there are contradictory results about the experimental
protocol to be used, and relating to the cytotoxicity caused by glu-
taraldehyde remaining in the sample after crosslinking reactions.
In this study, crosslinking was performed by immersion of HA in
water-acetone mixtures containing GA. Reaction was performed in
several steps with increasing water/acetone ratios. Higher GA
concentrations and higher crosslinking reaction times than the
literature were necessary in the addition to the multistep procedure
to obtain HA samples that do not dissolve in water within in vitro
culture times. Poly(L-lactic acid) tridimensional scaffolds were
made by compression moulding followed by particulate leaching,
and after the scaffolds’ impregnation with soluble HA and drying,
there was a subsequent crosslinking reaction with glutaraldehyde
with the procedure described above.
A morphological study and physical characterization of the
hybrid scaffolds, and preliminary results with human ﬁbroblasts
and human dental pulp mesenchymal cells show the ability of these
scaffolds for tissue engineering applications.
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Central nervous system trauma and neurodegenerative diseases
involve massive neuronal and glial cell death and loss of the three-
dimensional spatial organization and connectivity of the neuronal
networks. In this work we employ a biostable model system to
study differentiation and viability of neural precursors in 3D
scaffolds.
Polymer scaffolds with interconnected porous with 90 microns
of pore size were produced varying the hydrophobic-hydrophilic
monomeric units ratio along the polymer chain. The materials
studied, biocompatible and biostable, were polymer or copolymer
networks based on the hydrophobic homopolymer poly(ethyl ac-
rylate), PEA, and its copolymers with hydroxyethyl acrylate,
p(EA-co-HEA) and methacrylic acid, p(EA-co-MAAc). In these
biomaterials, the survival of differentiated functional neurons de-
rived from cultured subventricular zone (SVZ) postnatal neural
stem cells was investigated.
The tissues obtained from the SVZ of postnatal rats were plated
in DMEM/F12 basal medium, with EGF and FGF as single sus-
pensions. The formed spheres (neurospheres) were then collected
and dissociated mechanically, the new microspheres formed were
dissociated again and the process was repeated two times. After
dissociation at the third passage, cells were seeded onto the dif-
ferent biomaterials with a differentiation medium of neurospheres.
The neuronal cells were identiﬁed by immunocytochemical
labeling for the neuronal marker TUJ1, and for the glial marker
GFAP. The results with DAPI showed that in all the materials,
but mainly in p(EA-co-MAAc) scaffolds, cells survived inside
the pores of the biomaterial. These are promising results that prove
that these constructs have great potential in neuronal tissue engi-
neering.
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Cardiac diseases are the main cause of death in Western countries
and one of the most expensive diseases to treat for the health
services. Current therapies do not offer a complete cure, with the
exception of heart transplantations; however, the shortage of do-
nors limits the number of patients who can beneﬁt from this
treatment. Cardiac tissue engineering works towards the creation
of an engineered muscle by providing cardiomyocytes with
physical support and biochemical factors. This approach aims to
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